Renan Ozyerli, MD, MSD Turkey
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to…
Nobel is a long-standing, internationally active pharmaceutical company founded in 1964 with one hundred percent national capital, representing the Turkish brand in a wide range of geographies with its half a century of experience and respectful history.
Nobel performs its sales, marketing and management activities in Istanbul, manufacturing and R&D activities in Duzce, and API manufacturing in Cerkezkoy.
They produce:
• Painkillers and rheumatic medicines
• Antibiotics and fungicides
• Common cold medicines
• Digestive system medicines
• Urinary system medicines
• Cardiovascular system medicines
• Central nervous system medicines
• Food supplements like probiotics and fish oils
• Immune-enhancing vitamin and mineral supplements, bone, joint and cartilage health products, hair-nail and skin health products, cosmetics, personal hygiene and care products.
Nobel İlaç allocates 5% of its annual turnover to R&D activities, is the first organization supported by Turkey for the local development and manufacturing of biosimilar drugs in the framework of the 2023 vision.
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to…
Raphaël Esposito, director of the French Chamber of Commerce in Turkey, sheds light on issues ranging from venture partnerships to cultural specificities, while underlining Turkey’s capacity to respond to the…
Asli Özelli, newly appointed executive director of AmCham Turkey, discusses the economic landscape of Turkey and its attractiveness for American companies, in addition to highlighting her priorities in her new…
Hande Demirdere, general manager of Pierre Fabre Pharma in Turkey, sheds light on the affiliate’s impressive 93 percent growth in 2017 while highlighting where to target development opportunities in the…
Selim Giray, the recently appointed VP and general manager of GSK Turkey, provides insights into the company’s eye-catching footprint and commitment to Turkey, his ambition to integrate into the market’s…
In Summer 2018, we spoke to Adriano Antonio Treve, then general manager of Roche Turkey, now Area Head Central Eastern Europe, Turkey, Russia, Central Asia, Iran, Pakistan & Indian Subcontinent.…
Elif Aral, country manager of Pfizer Turkey, stresses that Turkey will continue to be perceived as essential and important, where healthcare is a top priority with its young but aging…
Mustafa Kemal Erol , president of the Turkish Society of Cardiology, introduces one of the oldest and largest societies in the country divulges their best collaborations with the Ministry of…
Abdi İbrahim Otsuka, the Turkish-Japanese hybrid pharmaceutical company, celebrated their five-year anniversary just last year and have ambitions to become the Number One Japanese company in Turkey. Elif Elkin, in…
Mark Dekker, general manager of Astellas in Turkey, describes the ever-increasing commitment of the company to Turkey and the recent doubling of Astellas’ portfolio in the country, while pinpointing the…
Mahmut Gümüş, president of the Turkish Society of Medical Oncology, paints a descriptive picture of the oncology situation in the country, with the looming epidemiological shift set to transform the…
Hakan Koçak, CEO–general manager of Koçak Farma, a company with 47 years in the pharmaceutical industry and the biggest production facility in Turkey, gives a thorough insight into Koçak Farma’s…
See our Cookie Privacy Policy Here
